ArticleThoracic cancer2020

DLL3 expression is a predictive marker of sensitivity to adjuvant chemotherapy for pulmonary LCNEC.

Hiroyuki Ogawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.